Who Can File an Antacid Lawsuit in New York?

You may qualify if you took an antacid containing ranitidine (sold as Zantac or generics) and were later diagnosed with a cancer such as bladder, stomach, esophageal, or colorectal cancer. Courts have examined long-term users who took the drug regularly for months or years. A personal injury attorney can review your medical records and prescription history to assess your eligibility.

New York applies CPLR §214-c to injuries caused by long-term exposure to a substance like ranitidine. Instead of starting the clock on the date you took the drug, this rule generally gives you 3 years from the date you discovered — or reasonably should have discovered — that your illness was caused by the medication, not 3 years from when you took it. Because timing rules for mass tort and multidistrict litigation deadlines can differ from this state-law standard, consult an attorney promptly to confirm which deadline applies to your case.

Ranitidine, the active ingredient in Zantac, was found to contain or produce NDMA (N-nitrosodimethylamine), a probable human carcinogen. Cancers most commonly cited in litigation include bladder, stomach, esophageal, kidney, colorectal, and liver cancer. The FDA recalled all ranitidine products in April 2020 after detecting unacceptably high NDMA levels.

Document everything: save prescription records, pharmacy receipts, or medication bottles showing you took ranitidine, and gather all medical records related to your diagnosis. Because New York’s 3-year filing window can close quickly -- and mass tort deadlines can differ -- speak with a personal injury attorney promptly. Most attorneys offer a free consultation and can evaluate your case at no cost.